194 related articles for article (PubMed ID: 8662803)
1. Aggregation of the FcepsilonRI on mast cells stimulates c-Jun amino-terminal kinase activity. A response inhibited by wortmannin.
Ishizuka T; Oshiba A; Sakata N; Terada N; Johnson GL; Gelfand EW
J Biol Chem; 1996 May; 271(22):12762-6. PubMed ID: 8662803
[TBL] [Abstract][Full Text] [Related]
2. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases.
Ishizuka T; Terada N; Gerwins P; Hamelmann E; Oshiba A; Fanger GR; Johnson GL; Gelfand EW
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6358-63. PubMed ID: 9177222
[TBL] [Abstract][Full Text] [Related]
3. Mitogen-activated protein kinase activation through Fc epsilon receptor I and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells.
Ishizuka T; Chayama K; Takeda K; Hamelmann E; Terada N; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1999 Feb; 162(4):2087-94. PubMed ID: 9973482
[TBL] [Abstract][Full Text] [Related]
4. Stem cell factor augments Fc epsilon RI-mediated TNF-alpha production and stimulates MAP kinases via a different pathway in MC/9 mast cells.
Ishizuka T; Kawasome H; Terada N; Takeda K; Gerwins P; Keller GM; Johnson GL; Gelfand EW
J Immunol; 1998 Oct; 161(7):3624-30. PubMed ID: 9759885
[TBL] [Abstract][Full Text] [Related]
5. Multiple signaling pathways for the activation of JNK in mast cells: involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7.
Kawakami Y; Hartman SE; Holland PM; Cooper JA; Kawakami T
J Immunol; 1998 Aug; 161(4):1795-802. PubMed ID: 9712046
[TBL] [Abstract][Full Text] [Related]
6. Bruton's tyrosine kinase-mediated interleukin-2 gene activation in mast cells. Dependence on the c-Jun N-terminal kinase activation pathway.
Hata D; Kitaura J; Hartman SE; Kawakami Y; Yokota T; Kawakami T
J Biol Chem; 1998 May; 273(18):10979-87. PubMed ID: 9556577
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells.
Hirasawa N; Sato Y; Fujita Y; Mue S; Ohuchi K
J Immunol; 1998 Nov; 161(9):4939-43. PubMed ID: 9794429
[TBL] [Abstract][Full Text] [Related]
8. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.
Teramoto H; Salem P; Robbins KC; Bustelo XR; Gutkind JS
J Biol Chem; 1997 Apr; 272(16):10751-5. PubMed ID: 9099726
[TBL] [Abstract][Full Text] [Related]
10. A novel human STE20-related protein kinase, HGK, that specifically activates the c-Jun N-terminal kinase signaling pathway.
Yao Z; Zhou G; Wang XS; Brown A; Diener K; Gan H; Tan TH
J Biol Chem; 1999 Jan; 274(4):2118-25. PubMed ID: 9890973
[TBL] [Abstract][Full Text] [Related]
11. Sensitized mast cells migrate toward the antigen: a response regulated by p38 mitogen-activated protein kinase and Rho-associated coiled-coil-forming protein kinase.
Ishizuka T; Okajima F; Ishiwara M; Iizuka K; Ichimonji I; Kawata T; Tsukagoshi H; Dobashi K; Nakazawa T; Mori M
J Immunol; 2001 Aug; 167(4):2298-304. PubMed ID: 11490018
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of the ERK, JNK, and p38 mitogen-activated protein kinases by CD40 and the B cell antigen receptor.
Sutherland CL; Heath AW; Pelech SL; Young PR; Gold MR
J Immunol; 1996 Oct; 157(8):3381-90. PubMed ID: 8871635
[TBL] [Abstract][Full Text] [Related]
13. Negative regulation of FcepsilonRI-mediated mast cell activation by a ubiquitin-protein ligase Cbl-b.
Qu X; Sada K; Kyo S; Maeno K; Miah SM; Yamamura H
Blood; 2004 Mar; 103(5):1779-86. PubMed ID: 14604964
[TBL] [Abstract][Full Text] [Related]
14. Chemotactic peptide-induced activation of MEK-2, the predominant isoform in human neutrophils. Inhibition by wortmannin.
Downey GP; Butler JR; Brumell J; Borregaard N; Kjeldsen L; Sue-A-Quan AK; Grinstein S
J Biol Chem; 1996 Aug; 271(35):21005-1011. PubMed ID: 8702863
[TBL] [Abstract][Full Text] [Related]
15. MEKK2 gene disruption causes loss of cytokine production in response to IgE and c-Kit ligand stimulation of ES cell-derived mast cells.
Garrington TP; Ishizuka T; Papst PJ; Chayama K; Webb S; Yujiri T; Sun W; Sather S; Russell DM; Gibson SB; Keller G; Gelfand EW; Johnson GL
EMBO J; 2000 Oct; 19(20):5387-95. PubMed ID: 11032806
[TBL] [Abstract][Full Text] [Related]
16. MEK kinases are regulated by EGF and selectively interact with Rac/Cdc42.
Fanger GR; Johnson NL; Johnson GL
EMBO J; 1997 Aug; 16(16):4961-72. PubMed ID: 9305638
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of multiple mitogen-activated protein kinase sub-families by oxidative stress and phosphorylation of the small heat shock protein, HSP25/27, in neonatal ventricular myocytes.
Clerk A; Michael A; Sugden PH
Biochem J; 1998 Aug; 333 ( Pt 3)(Pt 3):581-9. PubMed ID: 9677316
[TBL] [Abstract][Full Text] [Related]
18. Identification of c-Jun NH2-terminal protein kinase (JNK)-activating kinase 2 as an activator of JNK but not p38.
Lu X; Nemoto S; Lin A
J Biol Chem; 1997 Oct; 272(40):24751-4. PubMed ID: 9312068
[TBL] [Abstract][Full Text] [Related]
19. Ligation of major histocompatability complex (MHC) class I molecules on human T cells induces cell death through PI-3 kinase-induced c-Jun NH2-terminal kinase activity: a novel apoptotic pathway distinct from Fas-induced apoptosis.
Skov S; Klausen P; Claesson MH
J Cell Biol; 1997 Dec; 139(6):1523-31. PubMed ID: 9396757
[TBL] [Abstract][Full Text] [Related]
20. Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2.
Lin A; Minden A; Martinetto H; Claret FX; Lange-Carter C; Mercurio F; Johnson GL; Karin M
Science; 1995 Apr; 268(5208):286-90. PubMed ID: 7716521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
